PBSVPharma-Bio Serv, Inc.
Earnings
When Pharma-Bio Serv, Inc. reports, what it reported each quarter, and how the stock took the results.
64 quarters. Jul 31, 2010 to Jul 31, 2026. USD.
Next results · Q4 2026Projected
Jan 28, after the close
Thu, Jan 28, 2027in 81 days
Projected from its last 8 releases. The company has not named the day yet.
- Quarter
- Q4 2026 · Ended Oct 31, 2026
- 10-K window
- Jan 26 – Feb 4
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- $2.15M
- Revenue, change from a year earlier: Q3 2026 +19.0%, Q2 2026 +11.8%, Q1 2026 −7.1%, Q4 2025 −7.9%
- Net income
- -$102.00
- Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 +144.3%, Q1 2026 +285.0%, Q4 2025 n/m
- EPS
- —
- EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 +150.0%, Q1 2026 n/m, Q3 2025 n/m
Latest results
- Revenue
- $2.34M
- +19.0%
- Net income
- -$14.22K
- N/M
- EPS
- -$0.00
- N/M
- Revenue
- $2.70M
- +11.8%
- Net income
- $232.99K
- +144.3%
- EPS
- $0.01
- +150.0%
- Revenue
- $2.29M
- −7.1%
- Net income
- $32.86K
- +285.0%
- EPS
- $0.00
- —
- Revenue
- $2.15M
- −7.9%
- Net income
- -$102.00
- N/M
- EPS
- —
- —
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Jul 31, 2026 | Sep 14, 2026 · after-hours | Sep 14, 2026 | 45 d | 10-Q | $2.34M | +19.0% | -$0.00 | — | |
| Q2 2026 | Apr 30, 2026 | Jun 15, 2026 · after-hours | Jun 15, 2026 | 46 d | 10-Q | $2.70M | +11.8% | $0.01 | — | |
| Q1 2026 | Jan 31, 2026 | Mar 17, 2026 · after-hours | Mar 17, 2026 | 45 d | 10-Q | $2.29M | −7.1% | $0.00 | — | |
| FY 2025 | ||||||||||
| Q4 2025derived | Oct 31, 2025 | Jan 29, 2026 · after-hours | Jan 29, 2026 | 90 d | 10-K | $2.15M | −7.9% | — | — | |
| Q3 2025 | Jul 31, 2025 | Sep 15, 2025 · after-hours | Sep 15, 2025 | 46 d | 10-Q | $1.96M | −18.8% | -$0.01 | — | |
| Q2 2025 | Apr 30, 2025 | Jun 16, 2025 · after-hours | Jun 16, 2025 | 47 d | 10-Q | $2.42M | +1.7% | $0.00 | — | |
| Q1 2025 | Jan 31, 2025 | Mar 17, 2025 · after-hours | Mar 17, 2025 | 45 d | 10-Q | $2.47M | +3.8% | $0.00 | — | |
| FY 2024 | ||||||||||
| Q4 2024derived | Oct 31, 2024 | Jan 29, 2025 · after-hours | Jan 29, 2025 | 90 d | 10-K | $2.33M | −35.2% | — | — | |
| Q3 2024 | Jul 31, 2024 | Sep 16, 2024 · after-hours | Sep 16, 2024 | 47 d | 10-Q | $2.42M | −47.2% | $0.01 | — | |
| Q2 2024 | Apr 30, 2024 | Jun 14, 2024 · after-hours | Jun 14, 2024 | 45 d | 10-Q | $2.38M | −47.9% | -$0.01 | — | |
| Q1 2024 | Jan 31, 2024 | Mar 18, 2024 · after-hours | Mar 18, 2024 | 47 d | 10-Q | $2.38M | −43.8% | -$0.01 | — | |
| FY 2023 | ||||||||||
| Q4 2023derived | Oct 31, 2023 | Jan 29, 2024 · after-hours | Jan 29, 2024 | 90 d | 10-K | $3.60M | −22.4% | — | 15.0% | |
| Q3 2023 | Jul 31, 2023 | Sep 14, 2023 · after-hours | Sep 14, 2023 | 45 d | 10-Q | $4.58M | −4.1% | — | — | |
| Q2 2023 | Apr 30, 2023 | Jun 14, 2023 · after-hours | Jun 14, 2023 | 45 d | 10-Q | $4.56M | −8.1% | — | — | |
| Q1 2023 | Jan 31, 2023 | Mar 17, 2023 · after-hours | Mar 17, 2023 | 45 d | 10-Q | $4.24M | −15.6% | — | — | |
| FY 2022 | ||||||||||
| Q4 2022derived | Oct 31, 2022 | — | Jan 30, 2023 | 91 d | 10-K | $4.64M | −17.1% | — | — | |
| Q3 2022 | Jul 31, 2022 | Sep 14, 2022 · after-hours | Sep 14, 2022 | 45 d | 10-Q | $4.77M | −4.3% | — | — | |
| Q2 2022 | Apr 30, 2022 | Jun 14, 2022 · after-hours | Jun 14, 2022 | 45 d | 10-Q | $4.97M | −1.5% | — | 12.5% | |
| Q1 2022 | Jan 31, 2022 | Mar 17, 2022 · after-hours | Mar 17, 2022 | 45 d | 10-Q | $5.02M | +11.8% | — | — | |
| FY 2021 | ||||||||||
| Q4 2021derived | Oct 31, 2021 | — | Feb 11, 2022 | 103 d | 10-K | $5.60M | +11.4% | — | — | |
| Q3 2021 | Jul 31, 2021 | Sep 14, 2021 · after-hours | Sep 14, 2021 | 45 d | 10-Q | $4.99M | −20.6% | — | — | |
| Q2 2021 | Apr 30, 2021 | Jun 14, 2021 · after-hours | Jun 14, 2021 | 45 d | 10-Q | $5.04M | −10.7% | — | — | |
| Q1 2021 | Jan 31, 2021 | Mar 17, 2021 · after-hours | Mar 17, 2021 | 45 d | 10-Q | $4.49M | −2.7% | — | 27.0% | |
| FY 2020 | ||||||||||
| Q4 2020derived | Oct 31, 2020 | — | Feb 1, 2021 | 93 d | 10-K | $5.03M | +4.2% | — | — | |
| Q3 2020 | Jul 31, 2020 | — | Sep 14, 2020 | 45 d | 10-Q | $6.28M | +26.4% | — | — | |
| Q2 2020 | Apr 30, 2020 | Jun 15, 2020 · after-hours | Jun 15, 2020 | 46 d | 10-Q | $5.65M | +9.7% | — | — | |
| Q1 2020 | Jan 31, 2020 | Mar 16, 2020 · after-hours | Mar 16, 2020 | 45 d | 10-Q | $4.61M | +1.0% | — | — | |
| FY 2019 | ||||||||||
| Q4 2019derived | Oct 31, 2019 | Jan 29, 2020 · after-hours | Jan 29, 2020 | 90 d | 10-K | $4.82M | −15.0% | — | — | |
| Q3 2019 | Jul 31, 2019 | Sep 16, 2019 · after-hours | Sep 16, 2019 | 47 d | 10-Q | $4.97M | +7.2% | — | — | |
| Q2 2019 | Apr 30, 2019 | Jun 14, 2019 · after-hours | Jun 14, 2019 | 45 d | 10-Q | $5.15M | +36.8% | — | — | |
| Q1 2019 | Jan 31, 2019 | Mar 18, 2019 · after-hours | Mar 18, 2019 | 46 d | 10-Q | $4.57M | +22.5% | — | — | |
| FY 2018 | ||||||||||
| Q4 2018derived | Oct 31, 2018 | Jan 29, 2019 · after-hours | Jan 29, 2019 | 90 d | 10-K | $5.67M | — | — | 0.0% | |
| Q3 2018 | Jul 31, 2018 | Sep 14, 2018 · after-hours | Sep 14, 2018 | 45 d | 10-Q | $4.63M | +16.4% | $0.03 | — | |
| Q2 2018 | Apr 30, 2018 | Jun 14, 2018 · after-hours | Jun 14, 2018 | 45 d | 10-Q | $3.77M | −4.0% | -$0.01 | — | |
| Q1 2018 | Jan 31, 2018 | Mar 19, 2018 · after-hours | Mar 19, 2018 | 47 d | 10-Q | $3.73M | — | -$0.12 | — | |
| FY 2017 | ||||||||||
| Q4 2017derived | Oct 31, 2017 | Jan 29, 2018 · after-hours | Jan 29, 2018 | 90 d | 10-K | — | — | — | 0.0% | |
| Q3 2017 | Jul 31, 2017 | Sep 14, 2017 · after-hours | Sep 14, 2017 | 45 d | 10-Q | $3.98M | — | -$0.01 | — | |
| Q2 2017 | Apr 30, 2017 | Jun 14, 2017 · after-hours | Jun 14, 2017 | 45 d | 10-Q | $3.92M | — | -$0.01 | — | |
| Q1 2017 | Jan 31, 2017 | Mar 17, 2017 · after-hours | Mar 17, 2017 | 45 d | 10-Q | — | — | -$0.02 | — | |
| FY 2016 | ||||||||||
| Q4 2016derived | Oct 31, 2016 | — | Jan 31, 2017 | 92 d | 10-K | — | — | — | — | |
| Q3 2016 | Jul 31, 2016 | — | Sep 14, 2016 | 45 d | 10-Q | — | — | -$0.01 | — | |
| Q2 2016 | Apr 30, 2016 | — | Jun 14, 2016 | 45 d | 10-Q | — | — | $0.00 | — | |
| Q1 2016 | Jan 31, 2016 | — | Mar 16, 2016 | 45 d | 10-Q | — | — | $0.02 | — | |
| FY 2015 | ||||||||||
| Q4 2015derived | Oct 31, 2015 | — | Jan 29, 2016 | 90 d | 10-K | — | — | — | — | |
| Q3 2015 | Jul 31, 2015 | — | Sep 14, 2015 | 45 d | 10-Q | — | — | $0.02 | — | |
| Q2 2015 | Apr 30, 2015 | — | Jun 15, 2015 | 46 d | 10-Q | — | — | $0.02 | — | |
| Q1 2015 | Jan 31, 2015 | — | Mar 17, 2015 | 45 d | 10-Q | — | — | $0.01 | — | |
| FY 2014 | ||||||||||
| Q4 2014derived | Oct 31, 2014 | — | Jan 29, 2015 | 90 d | 10-K | — | — | — | — | |
| Q3 2014 | Jul 31, 2014 | — | Sep 15, 2014 | 46 d | 10-Q | — | — | $0.03 | — | |
| Q2 2014 | Apr 30, 2014 | — | Jun 16, 2014 | 47 d | 10-Q | — | — | $0.01 | 21.3% | |
| Q1 2014 | Jan 31, 2014 | — | Mar 17, 2014 | 45 d | 10-Q | — | — | $0.03 | — | |
| FY 2013 | ||||||||||
| Q4 2013derived | Oct 31, 2013 | — | Jan 29, 2014 | 90 d | 10-K | — | — | — | — | |
| Q3 2013 | Jul 31, 2013 | — | Sep 16, 2013 | 47 d | 10-Q | — | — | $0.05 | — | |
| Q2 2013 | Apr 30, 2013 | — | Jun 14, 2013 | 45 d | 10-Q | — | — | $0.06 | +8.7% | |
| Q1 2013 | Jan 31, 2013 | — | Mar 18, 2013 | 46 d | 10-Q | — | — | $0.05 | 13.7% | |
| FY 2012 | ||||||||||
| Q4 2012derived | Oct 31, 2012 | — | Jan 29, 2013 | 90 d | 10-K | — | — | — | — | |
| Q3 2012 | Jul 31, 2012 | — | Sep 14, 2012 | 45 d | 10-Q | — | — | $0.06 | — | |
| Q2 2012 | Apr 30, 2012 | — | Jun 14, 2012 | 45 d | 10-Q | — | — | $0.05 | — | |
| Q1 2012 | Jan 31, 2012 | — | Mar 16, 2012 | 45 d | 10-Q | — | — | $0.05 | — | |
| FY 2011 | ||||||||||
| Q4 2011derived | Oct 31, 2011 | — | Jan 30, 2012 | 91 d | 10-K | — | — | — | — | |
| Q3 2011 | Jul 31, 2011 | — | Sep 14, 2011 | 45 d | 10-Q | — | — | $0.07 | — | |
| Q2 2011 | Apr 30, 2011 | — | Jun 14, 2011 | 45 d | 10-Q | — | — | $0.02 | — | |
| Q1 2011 | Jan 31, 2011 | — | Mar 17, 2011 | 45 d | 10-Q | — | — | $0.02 | — | |
| FY 2010 | ||||||||||
| Q3 2010 | Jul 31, 2010 | — | Sep 14, 2010 | 45 d | 10-Q | — | — | $0.01 | 96.9% | |
Earlier years, FY 2010 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR